Suppr超能文献

幽门螺杆菌的中性粒细胞激活蛋白促进Th1免疫反应。

The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.

作者信息

Amedei Amedeo, Cappon Andrea, Codolo Gaia, Cabrelle Anna, Polenghi Alessandra, Benagiano Marisa, Tasca Elisabetta, Azzurri Annalisa, D'Elios Mario Milco, Del Prete Gianfranco, de Bernard Marina

机构信息

Department of Internal Medicine, University of Florence, Florence, Italy.

出版信息

J Clin Invest. 2006 Apr;116(4):1092-101. doi: 10.1172/JCI27177. Epub 2006 Mar 16.

Abstract

The Helicobacter pylori neutrophil-activating protein (HP-NAP) is a virulence factor of H. pylori that stimulates in neutrophils high production of oxygen radicals and adhesion to endothelial cells. We report here that HP-NAP is a TLR2 agonist able to induce the expression of IL-12 and IL-23 by neutrophils and monocytes. Addition in culture of HP-NAP, as an immune modulator, to antigen-induced T cell lines resulted in a remarkable increase in the number of IFN-gamma-producing T cells and decrease of IL-4-secreting cells, thus shifting the cytokine profile of antigen-activated human T cells from Th2 to a Th1 cytotoxic phenotype. We also found that in vivo HP-NAP elicited an antigen-specific Th1-polarized T cell response in the gastric mucosa of H. pylori-infected patients. These data indicate HP-NAP as an important factor of H. pylori able to elicit cells of the innate immune system to produce IL-12 and IL-23, and they suggest it as a new tool for promoting Th1 immune responses.

摘要

幽门螺杆菌中性粒细胞激活蛋白(HP-NAP)是幽门螺杆菌的一种毒力因子,可刺激中性粒细胞大量产生氧自由基并使其黏附于内皮细胞。我们在此报告,HP-NAP是一种Toll样受体2(TLR2)激动剂,能够诱导中性粒细胞和单核细胞表达白细胞介素-12(IL-12)和白细胞介素-23(IL-23)。作为免疫调节剂,在培养物中添加HP-NAP至抗原诱导的T细胞系,可使产生γ干扰素(IFN-γ)的T细胞数量显著增加,分泌白细胞介素-4(IL-)的细胞数量减少,从而使抗原激活的人T细胞的细胞因子谱从辅助性T细胞2(Th2)型转变为Th1细胞毒性表型。我们还发现,在体内,HP-NAP在幽门螺杆菌感染患者的胃黏膜中引发了抗原特异性的Th1极化T细胞反应。这些数据表明,HP-NAP是幽门螺杆菌的一个重要因子,能够促使先天性免疫系统细胞产生IL-12和IL-23,并提示它可作为促进Th1免疫反应的一种新工具。

相似文献

1
The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.
J Clin Invest. 2006 Apr;116(4):1092-101. doi: 10.1172/JCI27177. Epub 2006 Mar 16.
3
The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.
FEMS Immunol Med Microbiol. 2007 Jul;50(2):157-64. doi: 10.1111/j.1574-695X.2007.00258.x. Epub 2007 May 22.
5
VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation.
Clin Chim Acta. 2007 May;381(1):32-8. doi: 10.1016/j.cca.2007.02.026. Epub 2007 Feb 21.
7
Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein.
J Allergy Clin Immunol. 2008 Nov;122(5):908-913.e5. doi: 10.1016/j.jaci.2008.08.016. Epub 2008 Sep 19.
8
Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.
World J Gastroenterol. 2014 May 14;20(18):5294-301. doi: 10.3748/wjg.v20.i18.5294.
9
Th1 and Th17 responses to Helicobacter pylori in Bangladeshi infants, children and adults.
PLoS One. 2014 Apr 8;9(4):e93943. doi: 10.1371/journal.pone.0093943. eCollection 2014.
10
The neutrophil-activating protein of Helicobacter pylori.
Int J Med Microbiol. 2002 Feb;291(6-7):545-50. doi: 10.1078/1438-4221-00165.

引用本文的文献

2
Cross-Kingdom Pathogenesis of CQ10: Insights from Transcriptome and Proteome Analyses.
Microorganisms. 2024 Oct 30;12(11):2197. doi: 10.3390/microorganisms12112197.
3
Effects and mechanisms of on cancers development and immunotherapy.
Front Immunol. 2024 Oct 7;15:1469096. doi: 10.3389/fimmu.2024.1469096. eCollection 2024.
6
Special Issue "Bacterial Toxins and Cancer".
Int J Mol Sci. 2024 Feb 9;25(4):2128. doi: 10.3390/ijms25042128.
7
An intranasal influenza virus vector vaccine protects against in mice.
J Virol. 2024 Mar 19;98(3):e0192323. doi: 10.1128/jvi.01923-23. Epub 2024 Feb 15.
8
Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity.
Infection. 2024 Apr;52(2):345-384. doi: 10.1007/s15010-023-02159-9. Epub 2024 Jan 25.
9
Microbiome in Cancer Development and Treatment.
Microorganisms. 2023 Dec 22;12(1):24. doi: 10.3390/microorganisms12010024.
10
Pathogenomics of Helicobacter pylori.
Curr Top Microbiol Immunol. 2023;444:117-155. doi: 10.1007/978-3-031-47331-9_5.

本文引用的文献

2
Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori.
Infect Immun. 2004 Aug;72(8):4416-23. doi: 10.1128/IAI.72.8.4416-4423.2004.
3
Toll-like receptor signalling.
Nat Rev Immunol. 2004 Jul;4(7):499-511. doi: 10.1038/nri1391.
5
Helicobacter pylori persistence: biology and disease.
J Clin Invest. 2004 Feb;113(3):321-33. doi: 10.1172/JCI20925.
6
The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms.
J Exp Med. 2003 Dec 15;198(12):1887-97. doi: 10.1084/jem.20030621.
7
9
Interleukin-12 and the regulation of innate resistance and adaptive immunity.
Nat Rev Immunol. 2003 Feb;3(2):133-46. doi: 10.1038/nri1001.
10
Toll-like receptors.
Annu Rev Immunol. 2003;21:335-76. doi: 10.1146/annurev.immunol.21.120601.141126. Epub 2001 Dec 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验